fda stops semaglutide approves Ozempic® (semaglutide) as the only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease 📢 FDA has determined the

Find out more about the association between GLP-1 use in patients with Type 2 diabetes and erectile dysfunction.

Looking for a low-calorie sugar that tastes and bakes just like the real thing? It's Just Allulose has you covered

Discover how GLP-1 receptor agonists like semaglutide may reduce inflammation beyond blood sugar control

Shima Hadidchi MD Offered Semaglutide GLP-1 Injections to Help Obese Adults to Achieve Substantial Weight Loss & Improved Overall Health.

Brazil, Mexico will initially drive volume due to the relatively high obesity prevalence in these countries combined with a high absolute population

Hims & Hers pulls copycat Wegovy pill after legal pressure and FDA scrutiny, raising fresh questions about weight loss drug safety.